Janssen to Highlight Commitment to Lung Cancer Science and Innovation with Eight Data …
Janssen to Highlight Commitment to Lung Cancer Science and Innovation with Eight Data … RARITAN, N.J., Jan. 12, 2021 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that eight company-sponsored presentations, including two oral presentations, will be featured at the International Association for the Study of Lung Cancer’s (IASLC) 2020 World Conference […]
Read More